摘要 : Background. The recommended therapy for patients with chronic hepatitis C (CHC), genotype 1, who have cirrhosis and have failed prior therapy is 12 weeks of sofosbuvir (SOF), ledipasvir (LDV), and ribavirin (RBV). This recommendat... 展开
作者 | Fiona Clement Matthew James Paul Ronksley Karen L. Tang Kevork M. Peltekian William Stokes Carol Fenton |
---|---|
作者单位 | |
期刊名称 | 《Canadian journal of gastroenterology & hepatology.》 |
总页数 | 8 |
语种/中图分类号 | 英语 / R57 |
馆藏号 | N2017031600030789 |